xmas 2015, page-6

Ya gotta love Coolstocks.

When Pfizer announced its interest in TT-033 I think the sp hit a daily high of ~32c. I also think that, in pre-consolidation terms, there were about 1/4 the number of shares on the market. So, factoring in dilution the equivalent sp for the Pfizer announcement would be ~8c pre-consolidation . Post consolidation that would be $2.00 in round terms.

If the Pfizer announcement pushed up the sp to a $2.00 equivalent back then, when there was no clinical data, how much would a similar show of interest from a big pharma influence the sp when positive in human trial data is released?